Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vignesh T Packiam

Showing results (131-140 of 136) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 136 results.
European Urology Focus|February 8, 2025
Impact of Tumor Stage on Oncologic Outcomes of High-grade Bacillus Calmette-Guérin Unresponsive Non-muscle-invasive Bladder Cancer Undergoing Bladder-sparing TherapiesDrupad Annapureddy, Jacob I Taylor, Ashish M Kamat, et al.
BJU International|August 26, 2024
Long-term outcomes of bladder-sparing therapy vs radical cystectomy in BCG-unresponsive non-muscle-invasive bladder cancerJacob I Taylor, Ashish M Kamat, Michael A O'Donnell, et al.
European Urology|June 13, 2025
Computational Histology Artificial Intelligence (CHAI) Enhances Risk Stratification of High-grade Ta Non-muscle-invasive Bladder Cancer in a Multicenter Cohort: Comparison to Current European Association of Urology and American Urological Association Stratification SchemesSam S Chang, Bryn Launer, Vikram Narayan, et al.
European Urology Oncology|December 18, 2024
Oncologic Outcomes of Sequential Intravesical Gemcitabine and Docetaxel Compared with Bacillus Calmette-Guérin in Patients with Bacillus Calmette-Guérin-Unresponsive Non-Muscle Invasive Bladder CancerJacob Taylor, Ashish M Kamat, Drupad Annapureddy, et al.
European Urology Focus|August 15, 2024
Testicular Germ Cell Tumors with Venous Tumor Thrombus: Prevalence, Presentation, and ManagementSophia Y Chahine, Khalid Y Alkhatib, Gevorg Arakelyan, et al.
The Journal of Urology|October 9, 2024
Predicting Response to Intravesical Bacillus Calmette-Guérin in High-Risk Nonmuscle-Invasive Bladder Cancer Using an Artificial Intelligence-Powered Pathology Assay: Development and Validation in an International 12-Center CohortYair Lotan, Viswesh Krishna, Waleed M Abuzeid, et al.
Pageof 14

Showing results (131-140 of 136) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 136 results.
European Urology Focus|February 8, 2025
Impact of Tumor Stage on Oncologic Outcomes of High-grade Bacillus Calmette-Guérin Unresponsive Non-muscle-invasive Bladder Cancer Undergoing Bladder-sparing TherapiesDrupad Annapureddy, Jacob I Taylor, Ashish M Kamat, et al.
BJU International|August 26, 2024
Long-term outcomes of bladder-sparing therapy vs radical cystectomy in BCG-unresponsive non-muscle-invasive bladder cancerJacob I Taylor, Ashish M Kamat, Michael A O'Donnell, et al.
European Urology|June 13, 2025
Computational Histology Artificial Intelligence (CHAI) Enhances Risk Stratification of High-grade Ta Non-muscle-invasive Bladder Cancer in a Multicenter Cohort: Comparison to Current European Association of Urology and American Urological Association Stratification SchemesSam S Chang, Bryn Launer, Vikram Narayan, et al.
European Urology Oncology|December 18, 2024
Oncologic Outcomes of Sequential Intravesical Gemcitabine and Docetaxel Compared with Bacillus Calmette-Guérin in Patients with Bacillus Calmette-Guérin-Unresponsive Non-Muscle Invasive Bladder CancerJacob Taylor, Ashish M Kamat, Drupad Annapureddy, et al.
European Urology Focus|August 15, 2024
Testicular Germ Cell Tumors with Venous Tumor Thrombus: Prevalence, Presentation, and ManagementSophia Y Chahine, Khalid Y Alkhatib, Gevorg Arakelyan, et al.
The Journal of Urology|October 9, 2024
Predicting Response to Intravesical Bacillus Calmette-Guérin in High-Risk Nonmuscle-Invasive Bladder Cancer Using an Artificial Intelligence-Powered Pathology Assay: Development and Validation in an International 12-Center CohortYair Lotan, Viswesh Krishna, Waleed M Abuzeid, et al.
Pageof 14